Cooley M&A

JANUARY 19, 2023

The Inflation Reduction Act imposes a 1% excise tax on certain repurchases of stock of publicly traded US corporations (“Covered Corporations”) effected after December 31, 2022 (the “Excise Tax”). [1] For stock exchanged or issued in an M&A transaction, this generally will be the “closing date.”

M&A 52

M&A Capital Market Stock Mergers and Acquisitions 52

Software Equity Group

MAY 7, 2024

2023 saw a myriad of factors impact SaaS M&A multiples, including economic developments, technological advancements, and a public market rebound. In any given year, however, some sectors of the SaaS universe are more prosperous than others, depending on industry trends, global economics, and other influences.

M&A 52

M&A Valuation Economics Business 52

Software Equity Group

MAY 8, 2024

2023 saw a myriad of factors impact SaaS M&A multiples, including economic developments, technological advancements, and a public market rebound. In any given year, however, some sectors of the SaaS universe are more prosperous than others, depending on industry trends, global economics, and other influences.

M&A 52

M&A Valuation Economics Business 52

Focus Investment Banking

AUGUST 6, 2023

ESG isn’t just a matter for large, publicly traded companies. While many people see this as merely “doing the right thing,” there is also often an economic payoff. This is particularly true if your partners are publicly traded or foreign-owned. It’s increasingly becoming a must for small and medium-sized businesses.

Middle Market 52

Middle Market Business Government Profitability 52

MergersCorp M&A International

AUGUST 9, 2024

These funds typically invest in publicly traded securities and derivatives, allowing for a wide range of investment tactics that can include long and short positions, derivatives trading, and leveraging. Hedge funds also focus on maximizing returns in any market condition, whether bullish or bearish.

Private Equity 52

Private Equity Equities Funds Investment 52

Sica Fletcher

MAY 8, 2020

Sica | Fletcher believes Brown & Brown is the publicly traded company that is most comparable to private, middle market U.S. For owners and executives of private insurance brokers, Brown & Brown's first quarter earnings call provides a treasure trove of information. insurance brokers.

Insurance 52

Insurance Retail Debt Broker 52

Focus Investment Banking

JUNE 13, 2023

A big part of oncology is buying and billing chemotherapy, and we're able to improve their economics there substantially with national buying power,” Patton told OBR. Formerly owned by Tahoe Investment Group, which bought the company in April 2017, Alliance was acquired by Akumin, a publicly traded company, in June 2021 for $820 million.

Hospitality 52

Hospitality Private Equity Medical Mergers and Acquisitions 52

The TRADE

JULY 11, 2023

The FCA now has the task of preserving this sensitive balance in the detailed rules that come out next year,” Mike Carrodus, chief executive of Substantive Research, told The TRADE. The industry reacts to the UK’s new research proposal appeared first on The TRADE. The post A welcome freedom, temporary measure or futile task?:

Asset Management 40

Asset Management Investment Government Capital Market 40

Cooley M&A

MARCH 1, 2019

These include prevailing market sentiment, current appetite for acquisitions in a particular sector and the political and economic environment, all of which can change well within a given transaction timetable. The usual pros and cons of being a publicly traded company will also need to be considered. What’s the time frame?

IPO 52

IPO Valuation M&A Business 52

Intrepid Banker Insights

MARCH 28, 2023

Intrepid Investment Bankers Warning Signs Your Business’s Liquidity Needs Attention Mixed signals dominate economic headlines as concerns persist about a recession beginning in 2023, if it has not already begun. At the same time, employment remains strong, with the unemployment rate hitting an all-time low.

Capital 52

Capital Advisory Banking Bank 52

Software Equity Group

MARCH 13, 2023

Strategic buyers are publicly traded or privately owned software companies. Particularly notable is the significant decline in public strategic deals, which fell from 35% to 25% from 2021 to 2022. In previous economic downturns, such as 2008, private SaaS company valuations took a hit as public strategics were forced to cut back.

M&A 52

M&A Private Equity Equities S&P 52

Deal Law Wire

APRIL 1, 2021

The recent economic volatility has also seen an increase in the use of alternatives to one-time cash purchases in the context of M&A deals , including earnouts and working capital adjustments. As of February 11, 2021, the OSC gave the green light for the first publicly traded bitcoin exchange-traded funds in North America.

M&A 40

M&A Funds Accountant IT 40

The Deal

JULY 20, 2023

The Paul Singer-led activist fund reported a 13% economic exposure to NRG Energy Inc. Very few activist funds are capable of taking $300 million positions, in common shares or derivatives, in publicly traded companies, said Klein, who advises activist investors. NRG), worth about $1 billion, that’s likely in derivatives.

Funds 52

Funds Investors Shares Investment 52

Software Equity Group

FEBRUARY 28, 2023

Stock prices and valuations of many leading public SaaS companies have fallen drastically from the beginning of 2022—but while that will affect the private market, it does not necessarily spell doom and gloom. This post will examine the current state of public SaaS company valuations and what it means for private companies.

Valuation 52

Valuation M&A Stock Profitability 52

Wall Street Mojo

FEBRUARY 9, 2024

When listed as publicly traded companies, they mostly become small-cap and micro-cap stocks trading on the exchange. Such firms enjoy high growth rates and play a vital economic role. The classification helps investors gauge the performance and growth potential to make future investments.

Middle Market 52

Middle Market Bulge Bracket Private Equity Investment Banking 52

RKJ Partners

AUGUST 6, 2017

To be more specific, business valuation is a process involving a set of procedures and approaches used to gauge the economic value of an ownership interest in a business as a going concern. Essentially, comparable company analysis looks at the value of publicly traded companies.

M&A 40

M&A Valuation Mergers and Acquisitions Discounted Cash Flow 40

Software Equity Group

FEBRUARY 12, 2024

In recent years, software buyers have been keenly focused on gross revenue retention (GRR) and gross profit margin (GPM) , largely because strong performance in these areas provides security amid uncertain economic conditions. Financial buyers , usually PE firms, are not interested in integrating your company with their own.

M&A 52

M&A Mergers and Acquisitions Business Valuation 52

Cooley M&A

SEPTEMBER 16, 2022

In addition, currently public dual-class companies with transfer provisions that do not contain clear carve outs for the delivery of voting agreements in the M&A context should discuss with their advisers the possibility of adopting “clear day” amendments to their charters to include these carve outs. Vote-down termination fee (i.e.,

M&A 59

M&A IPO Shares Mergers and Acquisitions 59

Software Equity Group

OCTOBER 22, 2024

In today’s economic climate, retention is everything: Software companies with Net Revenue Retention (NRR) rates above 120% are trading at a remarkable 63% premium over the market median. Because in a world where growth is uncertain, retaining and expanding existing customers is the ultimate competitive advantage.

Valuation 52

Valuation Investors IT Management 52

Cooley M&A

JANUARY 25, 2023

Biopharmaceutical company Chimerix agreed to sell its worldwide rights to brincidofovir, including TEMBEXA, to Emergent BioSolutions in a transaction intended to enhance Chimerix’s balance sheet while allowing Chimerix to participate in the longer-term economics of the drug through milestone payments and royalties.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Mergers and Inquisitions

DECEMBER 4, 2024

No matter the economic climate, you can always bet on sports fans to show up for their favorite teams. However, one common point across all the verticals is that IPOs are not common because there aren’t that many publicly traded sports teams, stadiums, or arenas.

Investment Banking 105

Investment Banking Banking Bank Investment 105

Cooley M&A

JANUARY 22, 2021

A series of blockbuster deals rallied the NASDAQ 100 Technology Index to trade more than 20% higher than 2019, and Q3 2020 recorded the highest global M&A deal value in the technology sector this decade. [2] The US government implemented a number of economic stimulus measures that rippled across the M&A landscape. A Look Ahead.

M&A 40

M&A IPO Mergers and Acquisitions Business 40

Cooley M&A

JANUARY 20, 2022

Certain headwinds and other complicating factors, however, may have tamped down M&A activity in 2021, including: Antitrust regulators continuing to produce uncertainty, with the Federal Trade Commission announcing a number of key policy changes – the full impact of these policy changes on transactions remains to be seen.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Focus Investment Banking

FEBRUARY 11, 2025

Overcoming Marketplace Uncertainty Rising interest rates introduced a difficult environment for private equity recapitalizations (where private equity groups sell a portfolio company to another buyer), so few of the older PE-backed ophthalmology organizations traded hands over the last few years.

Private Equity 52

Private Equity Healthcare Equities Medical 52

Focus Investment Banking

DECEMBER 20, 2024

Cencora, one of the largest publicly-traded pharmaceutical companies in the world, distributes pharmaceuticals, over-the-counter healthcare products and other healthcare supplies and equipment to healthcare providers. Strong overall economic activity and lower interest rates.

Private Equity 52

Private Equity Healthcare Equities Sale 52

Cooley M&A

JANUARY 22, 2025

Looking ahead, expect the fruits of these efforts to free up valuable resources capital and management bandwidth that can be redirected toward higher-value, strategic acquisitions in 2025 as the general economic backdrop (inflation, interest rates, antitrust) looks to become more conducive to bigger bets.

M&A 64

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 64